Recombinant interferon-gamma (IFN-gamma) provided significant joint pain relief in psoriatic arthritis patients within 28 days. Lower doses were well-tolerated, but higher doses were needed to impact skin lesions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: